demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 severe or critically
IFN beta-1a SOLIDARITY ... Darazam ... Kalil ...
high-dose IFN beta-1a Darazam

1 studies excluded by filtering options 0

5402 Davoudi-Monfared, 2020 113high risk of bias